Skip to content
EntityQ861645· pop 33· linked from 172 articles

Gaucher's disease

Sign in to save

Also known as Gaucher disease, acid beta-glucosidase deficiency, glocucerebrosidase deficiency, glucosylceramide beta-glucosidase deficiency, kerasin thesaurismosis, lipoid histiocytosis (kerasin type), lipoid histiocytosis, Glucocerebrosidase deficiency

human disease characterized by deficiency of the enzyme glucocerebrosidase which results in the accumulation of harmful quantities of the glycolipid glucocerebroside throughout the body

Key facts

Other names
Gaucher's disease
Specialty
Endocrinology , neurology
Symptoms
Hepatosplenomegaly , hypersplenism , pancytopenia , joint pain, neurological symptoms (usually mild), yellowish skin, and osteoporosis
Complications
Cirrhosis , splenic rupture , bleeding, and infections
Usual onset
Young adulthood (Type I), infancy (Type II)
Duration
Lifelong
Types
Type I, type II, type III
Causes
Glucocerebrosidase deficiency
Risk factors
Having parents with the disease or are carriers of the disease
Diagnostic method
Genetic testing
Differential diagnosis
SMPD1-associated Niemann–Pick disease , Fabry disease
Prevention
Gene editing
Treatment
Enzyme replacement therapy
Medication
Alglucerase , imiglucerase , velaglucerase , taliglucerase alfa , miglustat , and eliglustat
Prognosis
Slightly shortened life expectancy (type I), death in early childhood (type II)
Frequency
1 in 100 people are carriers

via Wikipedia infobox

Research

7,338 papers

via PubMed

Wikidata facts

Subclass of
disease
Named after
Philippe Gaucher
Image
Acid beta glucosidase.png
Show 8 more facts
NCI Thesaurus ID
C61268
health specialty
neurology
drug or therapy used for treatment
miglustat
genetic association
PSAP
prevalence
0.00001225
on focus list of Wikimedia project
WikiProject Medicine
Commons category
Gaucher's disease
Sources (9)

via Wikidata · CC0

~15 min read

Encyclopedic overview

Gaucher's disease or Gaucher disease (/ɡoʊˈʃeɪ/) (GD) is a genetic disorder in which glucocerebroside (a sphingolipid, also known as glucosylceramide) accumulates in cells and certain organs. The disorder is characterized by bruising, fatigue, anemia, low blood platelet count and enlargement of the liver and spleen, and is caused by a hereditary deficiency of the enzyme glucocerebrosidase (also known as glucosylceramidase), which acts on glucocerebroside. When the enzyme is defective, glucocerebroside accumulates, particularly in white blood cells and especially in macrophages (mononuclear leukocytes, which is often a target for intracellular parasites). Glucocerebroside can collect in the spleen, liver, kidneys, lungs, brain, and bone marrow.

Manifestations may include enlarged spleen and liver, liver malfunction, skeletal disorders or bone lesions that may be painful, severe neurological complications, swelling of lymph nodes and (occasionally) adjacent joints, distended abdomen, a brownish tint to the skin, anemia, low blood platelet count, and yellow fatty deposits on the white of the eye (sclera). Persons seriously affected may also be more susceptible to infection. Some forms of Gaucher's disease may be treated with enzyme replacement therapy.

Excerpted from Wikipedia’s “Gaucher's disease” article, available under the CC BY-SA 4.0 licence.